Genotyping of Mycoplasma genitalium Suggests De Novo Acquisition of Antimicrobial Resistance in Queensland, Australia

J Clin Microbiol. 2020 Aug 24;58(9):e00641-20. doi: 10.1128/JCM.00641-20. Print 2020 Aug 24.

Authors

Emma L Sweeney¹, Jacob Tickner², Cheryl Bletchly³, Graeme R Nimmo^{3

4}, David M Whiley^{2

3}

Affiliations

¹ The University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Australia e.l.sweeney@uq.edu.au.
² The University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Australia.
³ Pathology Queensland Central Laboratory, Brisbane, Australia.
⁴ Griffith School of Medicine, Brisbane, Australia.

No abstract available

Keywords: AMR; Australia; MG309; Mycoplasma genitalium; antimicrobial resistance; genotyping; mgpB.

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / pharmacology
Australia / epidemiology
Drug Resistance, Bacterial
Genotype
Humans
Macrolides
Mycoplasma Infections* / epidemiology
Mycoplasma genitalium* / genetics
Queensland

Substances

Anti-Bacterial Agents
Macrolides